CLINICAL_TRIALS
trial_result
· 2012-08-15
Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis [Phase 2]
Summary
This clinical trial update reports the completion of a Phase 2 study evaluating nasal carbon dioxide as-needed for symptomatic relief in seasonal allergic rhini…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Capnia, Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED